If we assume that all 3.3m GLP-1 receptor agonist users are also sugar super-users, and that being on GLP-1 receptor agonist drugs results in a 30% decrease in sugar intake, this would result in a loss 80 thousand tonnes of sugar consumption in the UK as a result of these drugs
Can Ozempic cause gallbladder issues
Prevalence of vitamin D deficiency in childhood acute lymphoblastic leukemia and its association with adverse outcomes during induction phase of treatment
Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study
Our results suggest that thyroid cancer risk should be considered with GLP-1 receptor agonists, particularly in patients treated for 1 to 3 years, Jean-Luc Faillie, MD, PhD , professor and head of the department of medical pharmacology and toxicology at Montpellier University Hospital and University of Montpellier in France, and colleagues wrote